Ömer Kutay Mutlu

1PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jun 27, 2025
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis.

Neslihan Akdogan, Ömer Kutay Mutlu, Erdem Karabulut

Pageof 1

Frequent Collaborators

1 joint publications

Neslihan Akdogan

1 joint publications

Erdem Karabulut

1 joint publications

Basak Yalici-Armagan

1 joint publications

Duygu Gulseren

1 joint publications

Sibel Dogan

Frequent Collaborators

1 joint publications

Neslihan Akdogan

1 joint publications

Erdem Karabulut

1 joint publications

Basak Yalici-Armagan

1 joint publications

Duygu Gulseren

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

39.1K
See more related videos

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

39.1K
See more related videos